Mirum Pharmaceuticals, Inc. (MIRM)
93.99
+0.66
(+0.71%)
USD |
NASDAQ |
Nov 13, 16:00
94.05
+0.06
(+0.06%)
After-Hours: 19:59
Mirum Pharmaceuticals EPS Diluted (Quarterly) : -0.6221 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.6221 |
| June 30, 2026 | -1.061 |
| March 31, 2026 | -13.43 |
| December 31, 2025 | -0.111 |
| September 30, 2025 | 0.051 |
| June 30, 2025 | -0.1179 |
| March 31, 2025 | -0.3002 |
| December 31, 2024 | -0.4947 |
| September 30, 2024 | -0.2979 |
| June 30, 2024 | -0.5216 |
| March 31, 2024 | -0.5387 |
| December 31, 2023 | -0.7095 |
| September 30, 2023 | -0.5739 |
| June 30, 2023 | -1.943 |
| March 31, 2023 | -0.7997 |
| December 31, 2022 | -0.9915 |
| Date | Value |
|---|---|
| September 30, 2022 | -1.022 |
| June 30, 2022 | -0.837 |
| March 31, 2022 | -1.170 |
| December 31, 2021 | 1.882 |
| September 30, 2021 | -1.551 |
| June 30, 2021 | -1.450 |
| March 31, 2021 | -1.678 |
| December 31, 2020 | -1.425 |
| September 30, 2020 | -0.8557 |
| June 30, 2020 | -0.928 |
| March 31, 2020 | -0.8626 |
| December 31, 2019 | -0.7809 |
| September 30, 2019 | -0.6562 |
| June 30, 2019 | -0.5897 |
| March 31, 2019 | -0.2591 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Incyte Corp. | -3.861 |
| Galectin Therapeutics, Inc. | -0.1393 |
| TG Therapeutics, Inc. | 0.3557 |
| Ardelyx, Inc. | -0.003 |
| Kodiak Sciences, Inc. | -1.052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.77M |
| Revenue (Quarterly) | 185.72M |
| Total Expenses (Quarterly) | 226.49M |
| Enterprise Value | 6.499B |
| Gross Profit Margin (Quarterly) | 81.01% |
| Profit Margin (Quarterly) | -21.95% |
| Earnings Yield | -16.19% |
| Normalized Earnings Yield | -6.329 |